Citi downgraded QuidelOrtho (QDEL) to Neutral from Buy with a price target of $33, down from $40. The firm cites a lack of upside to the company’s mid-single-digit growth outlook for the downgrade. Citi sees challenges with the LEX launch and higher interest expense pressuring QuidelOrtho’s fiscal 2025 earnings.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QDEL: